FDA approval of generic Doxil could ease shortage

02/5/2013 | Reuters

Sun Pharma Global received FDA approval for its generic version of Johnson & Johnson's cancer drug Doxil. The approval may help address a severe shortage of the medication.

View Full Article in:

Reuters